Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $2.49 billion. The enterprise value is $2.22 billion.
| Market Cap | 2.49B |
| Enterprise Value | 2.22B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 205.30 million shares outstanding. The number of shares has decreased by -0.69% in one year.
| Shares Outstanding | 205.30M |
| Shares Change (YoY) | -0.69% |
| Shares Change (QoQ) | +1.18% |
| Owned by Insiders (%) | 49.34% |
| Owned by Institutions (%) | 47.60% |
| Float | 73.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 36.97 |
| PS Ratio | 7.24 |
| Forward PS | 6.23 |
| PB Ratio | n/a |
| P/FCF Ratio | 27.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.30, with an EV/FCF ratio of 24.37.
| EV / Earnings | n/a |
| EV / Sales | 6.48 |
| EV / EBITDA | 42.30 |
| EV / EBIT | 52.53 |
| EV / FCF | 24.37 |
Financial Position
The company has a current ratio of 1.61
| Current Ratio | 1.61 |
| Quick Ratio | 1.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.14 |
| Interest Coverage | 0.28 |
Financial Efficiency
Return on equity (ROE) is -710.20% and return on invested capital (ROIC) is -307.83%.
| Return on Equity (ROE) | -710.20% |
| Return on Assets (ROA) | -22.80% |
| Return on Capital (ROIC) | -307.83% |
| Revenue Per Employee | $340,732 |
| Profits Per Employee | -$110,979 |
| Employee Count | 1,008 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 5.24 |
Taxes
In the past 12 months, Cellebrite DI has paid $5.61 million in taxes.
| Income Tax | 5.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.33% in the last 52 weeks. The beta is 1.48, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | +68.33% |
| 50-Day Moving Average | 11.32 |
| 200-Day Moving Average | 9.61 |
| Relative Strength Index (RSI) | 60.62 |
| Average Volume (20 Days) | 1,403,961 |
Short Selling Information
The latest short interest is 2.20 million, so 1.07% of the outstanding shares have been sold short.
| Short Interest | 2.20M |
| Short Previous Month | 2.00M |
| Short % of Shares Out | 1.07% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | 1.87 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $343.46 million and -$111.87 million in losses. Loss per share was -$0.57.
| Revenue | 343.46M |
| Gross Profit | 289.37M |
| Operating Income | 42.35M |
| Pretax Income | -106.25M |
| Net Income | -111.87M |
| EBITDA | 52.59M |
| EBIT | 42.35M |
| Loss Per Share | -$0.57 |
Balance Sheet
The company has $276.55 million in cash and $12.95 million in debt, giving a net cash position of $263.61 million or $1.28 per share.
| Cash & Cash Equivalents | 276.55M |
| Total Debt | 12.95M |
| Net Cash | 263.61M |
| Net Cash Per Share | $1.28 |
| Equity (Book Value) | -26.71M |
| Book Value Per Share | -0.13 |
| Working Capital | 143.44M |
Cash Flow
In the last 12 months, operating cash flow was $99.62 million and capital expenditures -$8.35 million, giving a free cash flow of $91.27 million.
| Operating Cash Flow | 99.62M |
| Capital Expenditures | -8.35M |
| Free Cash Flow | 91.27M |
| FCF Per Share | $0.46 |
Margins
Gross margin is 84.25%, with operating and profit margins of 12.33% and -32.57%.
| Gross Margin | 84.25% |
| Operating Margin | 12.33% |
| Pretax Margin | -30.94% |
| Profit Margin | -32.57% |
| EBITDA Margin | 15.31% |
| EBIT Margin | 12.33% |
| FCF Margin | 26.58% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.69% |
| Shareholder Yield | 0.69% |
| Earnings Yield | -4.50% |
| FCF Yield | 3.67% |
Analyst Forecast
The average price target for Cellebrite DI is $13.14, which is 8.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.14 |
| Price Target Difference | 8.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 15.31% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 4.05 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 5 |